alexa

GET THE APP

Fumihiko Fujita | OMICS International

Journal of Oncology Research and Treatment
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Fumihiko Fujita

Department of Transplantation and Digestive Surgery, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan

Biography

Department of Transplantation and Digestive Surgery, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan

he/she has experience all these areas Lymph node metastasis, Mediastinum, Hilar cholangiocarcinoma
Publications

Bevacizumab (Bmab)+Dihydropyrimidine Dehydrogenase (DPD) Inhibitory Fluoropyrimidine (DIF) Combined Chemotherapy for the Treatment of Late-Stage Elderly Patients with Advanced/Recurent Colorectal Cancer (ARCC)

Purpose: In Japan, elderly people account for more than 20% of the total population. The incidence of elderly patients with advanced/recurrent colorectal cancer (ARCC) has also been increasing. However, the optimal regimen for elderly patients, especially those older than 75 years of age (late-stage elderly), has not been established. This study ai... Read More»

Kazuma Kobayashi, Fumihiko Fujita, Yusuke Inoue, Chika Sakimura, Sayaka Kuba, Taiiichiro Kosaka, Taiiichiro Kosaka, Kosho Yamanouchi, Kengo Kanetaka, Tamotsu Kuroki and Susumu Eguchi

Research Article: J Oncol Res Treat 2018, 3: 119

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top